Optimizing PrEP Uptake and Adherence Among Male Sex Workers

NCT05736614 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2025-05-09

No results posted yet for this study

Summary

"PrEPare for Work" is a randomized controlled trial (RCT) whose goal is to test the efficacy of a behavioral intervention (Short Title: PrEPare for Work) in improving PrEP uptake, adherence, and persistence among male sex workers (MSW)

Conditions

  • Prevention

Interventions

BEHAVIORAL

Stage 1 Strength Based Case Management (SBCM) Condition

Intervention participants will receive a trained SBCM to motivate, support, and assist in linkage to PrEP prescribers to help facilitate obtaining PrEP medication to initiate treatment.

BEHAVIORAL

Stage 2 PrEPare for Work Intervention Condition

Intervention participants will receive 1-on-1 adherence counseling and personalized daily text messaging reminders to increase PrEP adherence. Intervention participants will undergo three adherence intervention sessions (once per week for 3 weeks) with interventionist.

Sponsors & Collaborators

  • The Miriam Hospital

    collaborator OTHER
  • University of California, Los Angeles

    collaborator OTHER
  • Project Weber/RENEW

    collaborator UNKNOWN
  • Open Door Health

    collaborator UNKNOWN
  • National Institute of Nursing Research (NINR)

    collaborator NIH
  • Brown University

    lead OTHER

Principal Investigators

  • Katie Biello, PhD · Brown University School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-03
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05736614 on ClinicalTrials.gov